Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.Current Cancer Drug Targets publishes original research articles, letters, reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Following are the articles from the journal Reviews on Current Cancer Drug Targets, 15 Issue 2:

Article: Involvement of Mesenchymal Stem Cells in Cancer Progression and Metastases

Author(s): Astra I. Chang, Aaron H. Schwertschkow, Jan A. Nolta and Jian Wu

Article: MYC-Mediated Synthetic Lethality for Treating

Author(s): Xin Li, Xin A. Zhang, Xiaoqing Li, Wei Xie and Shiang

Article: Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications

Author(s): Jawed Akhtar Siddiqui, Aru Singh, Megha Chagtoo, Nidhi Singh, Madan Madhav Godbole and Bandana Chakravarti

Article: Atypical PKCι as Target for Glioblastoma Therapy

Author(s): Ian A.J. Lorimer

Article: The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies

Author(s): Jinming Shi, Aixin Hao, Qiang Zhang and Guangchao Sui

Article: Identification of VEGFR2-Binding Peptides Using High Throughput Bacterial Display Methods and Functional Assessment

Author(s): Kefeng Pu, Lihua Yuan, Lisha Chen, Anxin Wang, Xuan Zhou, Hailu Zhang and Yimin Zhu

For details, please visit: